Renaissance Technologies’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,018
| Closed | -$317K | – | 3782 |
|
|
2024
Q1 | $317K | Buy |
1,018
+140
| +16% | +$43.6K | ﹤0.01% | 3070 |
|
|
2023
Q4 | $230K | Sell |
878
-118
| -12% | -$30.9K | ﹤0.01% | 3085 |
|
|
2023
Q3 | $195K | Sell |
996
-424
| -30% | -$83K | ﹤0.01% | 3099 |
|
|
2023
Q2 | $292K | Buy |
1,420
+463
| +48% | +$95.2K | ﹤0.01% | 3137 |
|
|
2023
Q1 | $96K | Buy |
957
+213
| +29% | +$21.4K | ﹤0.01% | 3503 |
|
|
2022
Q4 | $117K | Sell |
744
-56
| -7% | -$8.81K | ﹤0.01% | 3570 |
|
|
2022
Q3 | $200K | Sell |
800
-20
| -2% | -$5K | ﹤0.01% | 3386 |
|
|
2022
Q2 | $232K | Buy |
820
+470
| +134% | +$133K | ﹤0.01% | 3581 |
|
|
2022
Q1 | $70K | Sell |
350
-690
| -66% | -$138K | ﹤0.01% | 3852 |
|
|
2021
Q4 | $227K | Buy |
+1,040
| New | +$227K | ﹤0.01% | 3464 |
|